🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Join Dr. Keller and worldwide collaborators illuminating the role of SMARCA2/4 in childhood alveolar rhabdomyosarcoma by targeted protein degradation with ACBI1. opnme.com/online-seminar…

Can you be the hero of this story? Our amazing IVIS-3D has just reached the end of it’s useful life! Can you help us replace the instrument? cc-tdi.kindful.com/?campaign=1224… With this critical instrument, more drugs will be validated to move to human clinical trials - faster! #cctdi

We’re thrilled to announce exciting progress on our Myoepithelial Carcinoma Biology & EWSR1 Orphan Cancers Drug Discovery Research Program! cc-tdi.org/mec-biology-an… For additional information on MEC and how you can get involved visit: curemec.org. #curemec #cctdi

Today is #GIVINGTUESDAY, will you join the movement? We're asking you to join us TODAY towards raising $10,000 for our new laboratory. All gifts make a lasting impact on our research. Thank you for allowing our team to continue our mission! cc-tdi.kindful.com/?campaign=1208…

Exciting progress is being made at our new lab! This week another big transformation will occur when drywall is installed. Thank you R&H Construction and ZGF Architects for their unwavering leadership and support! #MovingTheFuture #cctdi #childhoodcancerresearch

Today our collaborator Tristan Cates from ChampionsOncology visited. Champions Oncology and their team (Iman Habib, and now Stefano Cairo) have done so much to help us develop clinical trial concepts from preclinical testing partnerships. #childhoodcancer #cctdi

Make a year-end gift that truly matters. Our current blog post has a heartfelt parents perspective on supporting cc-TDI's mission. A link to the post can be found here: cc-tdi.org/your-support-m… Thank you to Amy for allowing us to highlight your story. #cctdi

Thank you to our newest corporate partner Solution Street for their support of our childhood cancer research mission. We're grateful to be named their charity of choice for 2023! #cctdi #givingbackchildhood #childhoodcancerresearch

Thank you LylaNsouliFoundation for their $100,000 grant supporting #DIPG research. This award funds the development of an antibody-drug conjugate (ADC) for DIPG, a universally fatal childhood brain cancer accounting for roughly 16% of pediatric central nervous system tumors.

Megan's Mission Coffee is now available in K cups thanks to our friends at Live Life Coffee Beans! $5 of each bag (or box) supports rhabdo research at cc-tdi in memory of Megan! livelifecoffeebeans.com/product-page/1…

We recently recieved a $100,000 grant to further study Ewing sarcoma treatment options thanks to generous support from Golf Fights Cancer. This award, honoring Pete Fox, allows us to continue addressing a pressing need in relapsed Ewing sarcoma patients. #thankyou #ewingsarcoma

We're excited to share our microscopic computed tomography (microCT) experts with the CLEE “sea creature” science program at Portland State EDU. We have published in this area lightly (pubmed.ncbi.nlm.nih.gov/18286615/), but working with Annie and Jason take us to a deeper level. #cctdi

Thank you to Shelby Sallee for nominating us to be a recipient of FCM Cares’ Holiday Giveback in which $3,228 was raised in support of cancer research. Shelby designated us in memory of her sister Rachel who passed in 2007 from rhabdomyosarcoma. #childhoodcancerresearch #cctdi

cc-TDI is hiring and Executive Director! Visit: cc-tdi.org/were-hiring-an… to learn more and apply. #givingbackchildhood #cctdi #childhoodcancerresearch #nonprofit #executivedirectorsearch

Wishing you all love and comfort this Valentines Day! Still struggling to find a meaningful last-minute gift for you loved one? Consider giving your heart to cc-TDI by making a donation in support of our research mission! cc-tdi.org #givingbackchildhood #cctdi

We are thrilled to recognize the Megan's Mission Foundation for their recent $100,000 grant award supporting rhabdomyosarcoma research at cc-TDI. A link to our press release can be found here: cc-tdi.org/megans-mission… #rhabdomyosarcomaresearch

cc-TDI would like to extend our support to all of those effected by childhood cancer. We are continuing to research in your honor so that one-day all childhood cancers are universally survivable. #internationalchildhoodcancerday #childhoodcancer #cctdi

Thank you Starr Children's Fund for your support! We really appreciate your partnership in our research mission. #childhoodcancerresearch #cctdi #givingbackchildhood

It is with grieving hearts that we announce the passing of our beloved Board Member Richard Levick. Richard was a staunch advocate of our mission and a dear friend. Charles shares his personal thoughts here: cc-tdi.org/the-passing-of… #cctdi #childhoodcancerresearch #levick

Our 2023 Wilms Tumor and Rhabdomyosarcoma Nanocourse, scheduled for August 7-11th, still has four spots available for Rhabdomyosarcoma families. If you are interested in learning more about this intensive research experience visit: cc-tdi.org/nanocourse/